Clinical trials
Phase 2 Body Weight trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Regeneron Pharmaceuticals | 2 |
| Aardvark Therapeutics, Inc. | 1 |
| Iowa City Veterans Affairs Medical Center | 1 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 1 |
| Neothetics, Inc | 1 |
| New Mexico Cancer Research Alliance | 1 |
| Pfizer | 1 |
| Rebecca Ashare | 1 |
| Shionogi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Body Weight | 15 |
| Obesity | 8 |
| Overweight | 5 |
| Nutrition Disorders | 3 |
| Overnutrition | 3 |
| Tobacco Use Disorder | 2 |
| Alcoholism | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Endocrine System Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.